Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of Racial/Ethnic Disparities in Hospitalization and Mortality in Patients With COVID-19 in New York City.
Ogedegbe G, Ravenell J, Adhikari S, Butler M, Cook T, Francois F, Iturrate E, Jean-Louis G, Jones SA, Onakomaiya D, Petrilli CM, Pulgarin C, Regan S, Reynolds H, Seixas A, Volpicelli FM, Horwitz LI. Ogedegbe G, et al. Among authors: iturrate e. JAMA Netw Open. 2020 Dec 1;3(12):e2026881. doi: 10.1001/jamanetworkopen.2020.26881. JAMA Netw Open. 2020. PMID: 33275153 Free PMC article.
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.
Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, Hausvater A, Newman JD, Berger JS, Bangalore S, Katz SD, Fishman GI, Kunichoff D, Chen Y, Ogedegbe G, Hochman JS. Reynolds HR, et al. Among authors: iturrate e. N Engl J Med. 2020 Jun 18;382(25):2441-2448. doi: 10.1056/NEJMoa2008975. Epub 2020 May 1. N Engl J Med. 2020. PMID: 32356628 Free PMC article.
RAAS Inhibitors and Risk of Covid-19. Reply.
Reynolds HR, Adhikari S, Iturrate E. Reynolds HR, et al. Among authors: iturrate e. N Engl J Med. 2020 Nov 12;383(20):1993-1994. doi: 10.1056/NEJMc2030446. Epub 2020 Oct 27. N Engl J Med. 2020. PMID: 33108107 No abstract available.
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
Berger JS, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Cheng Y, McVerry BJ, Kim KS, Lopes RD, Atassi B, Berry S, Bochicchio G, de Oliveira Antunes M, Farkouh ME, Greenstein Y, Hade EM, Hudock K, Hyzy R, Khatri P, Kindzelski A, Kirwan BA, Baumann Kreuziger L, Lawler PR, Leifer E, Lopez-Sendon Moreno J, Lopez-Sendon J, Luther JF, Nigro Maia L, Quigley J, Sherwin R, Wahid L, Wilson J, Hochman JS, Neal MD; ACTIV-4a Investigators. Berger JS, et al. JAMA. 2022 Jan 18;327(3):227-236. doi: 10.1001/jama.2021.23605. JAMA. 2022. PMID: 35040887 Free PMC article. Clinical Trial.
Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19.
Nln I, Fernandez-Ruiz R, Muskardin TLW, Paredes JL, Blazer AD, Tuminello S, Attur M, Iturrate E, Petrilli CM, Abramson SB, Chakravarti A, Niewold TB. Nln I, et al. Among authors: iturrate e. Transl Res. 2022 Jun;244:47-55. doi: 10.1016/j.trsl.2022.01.007. Epub 2022 Jan 31. Transl Res. 2022. PMID: 35114420 Free PMC article.
Clinical and genomic signatures of SARS-CoV-2 Delta breakthrough infections in New York.
Duerr R, Dimartino D, Marier C, Zappile P, Levine S, Francois F, Iturrate E, Wang G, Dittmann M, Lighter J, Elbel B, Troxel AB, Goldfeld KS, Heguy A. Duerr R, et al. Among authors: iturrate e. EBioMedicine. 2022 Aug;82:104141. doi: 10.1016/j.ebiom.2022.104141. Epub 2022 Jul 26. EBioMedicine. 2022. PMID: 35906172 Free PMC article.
42 results